BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11809709)

  • 1. Decreased B16F10 melanoma growth and impaired vascularization in telomerase-deficient mice with critically short telomeres.
    Franco S; Segura I; Riese HH; Blasco MA
    Cancer Res; 2002 Jan; 62(2):552-9. PubMed ID: 11809709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo modulation of angiogenesis by beta 2 glycoprotein I.
    Passam FH; Qi JC; Tanaka K; Matthaei KI; Krilis SA
    J Autoimmun; 2010 Nov; 35(3):232-40. PubMed ID: 20655705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of laminin-8 results in increased tumor neovascularization and metastasis in mice.
    Zhou Z; Doi M; Wang J; Cao R; Liu B; Chan KM; Kortesmaa J; Sorokin L; Cao Y; Tryggvason K
    Cancer Res; 2004 Jun; 64(12):4059-63. PubMed ID: 15205311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere dysfunction results in enhanced organismal sensitivity to the alkylating agent N-methyl-N-nitrosourea.
    González-Suárez E; Goytisolo FA; Flores JM; Blasco MA
    Cancer Res; 2003 Nov; 63(21):7047-50. PubMed ID: 14612493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth.
    Paschoalin T; Carmona AK; Rodrigues EG; Oliveira V; Monteiro HP; Juliano MA; Juliano L; Travassos LR
    Mol Cancer; 2007 Jul; 6():44. PubMed ID: 17620116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12.
    Gee MS; Koch CJ; Evans SM; Jenkins WT; Pletcher CH; Moore JS; Koblish HK; Lee J; Lord EM; Trinchieri G; Lee WM
    Cancer Res; 1999 Oct; 59(19):4882-9. PubMed ID: 10519400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres.
    Herrera E; Samper E; Martín-Caballero J; Flores JM; Lee HW; Blasco MA
    EMBO J; 1999 Jun; 18(11):2950-60. PubMed ID: 10357808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctional telomeres promote genomic instability and metastasis in the absence of telomerase activity in oncogene induced mammary cancer.
    Bojovic B; Crowe DL
    Mol Carcinog; 2013 Feb; 52(2):103-17. PubMed ID: 22086874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of mouse telomerase in highly proliferative organs.
    Lee HW; Blasco MA; Gottlieb GJ; Horner JW; Greider CW; DePinho RA
    Nature; 1998 Apr; 392(6676):569-74. PubMed ID: 9560153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
    Shoji T; Koyama H; Morioka T; Tanaka S; Kizu A; Motoyama K; Mori K; Fukumoto S; Shioi A; Shimogaito N; Takeuchi M; Yamamoto Y; Yonekura H; Yamamoto H; Nishizawa Y
    Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model.
    Kibbey MC; Grant DS; Kleinman HK
    J Natl Cancer Inst; 1992 Nov; 84(21):1633-8. PubMed ID: 1279183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of peripheral dopaminergic nerves stimulates malignant tumor growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis.
    Basu S; Sarkar C; Chakroborty D; Nagy J; Mitra RB; Dasgupta PS; Mukhopadhyay D
    Cancer Res; 2004 Aug; 64(16):5551-5. PubMed ID: 15313889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective angiostatic treatment in a murine metastatic and orthotopic hepatoma model.
    Raskopf E; Dzienisowicz C; Hilbert T; Rabe C; Leifeld L; Wernert N; Sauerbruch T; Prieto J; Qian C; Caselmann WH; Schmitz V
    Hepatology; 2005 Jun; 41(6):1233-40. PubMed ID: 15915456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment.
    Ju Z; Jiang H; Jaworski M; Rathinam C; Gompf A; Klein C; Trumpp A; Rudolph KL
    Nat Med; 2007 Jun; 13(6):742-7. PubMed ID: 17486088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of telomerase and telomere length on epidermal stem cell behavior.
    Flores I; Cayuela ML; Blasco MA
    Science; 2005 Aug; 309(5738):1253-6. PubMed ID: 16037417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor.
    Chen L; Lu Y; Wu JM; Xu B; Zhang LJ; Gao M; Zheng SZ; Wang AY; Zhang CB; Zhang WW; Lei N
    Biochem Biophys Res Commun; 2009 Aug; 386(2):374-9. PubMed ID: 19523924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis.
    Langley RR; Ramirez KM; Tsan RZ; Van Arsdall M; Nilsson MB; Fidler IJ
    Cancer Res; 2003 Jun; 63(11):2971-6. PubMed ID: 12782605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
    Lechel A; Holstege H; Begus Y; Schienke A; Kamino K; Lehmann U; Kubicka S; Schirmacher P; Jonkers J; Rudolph KL
    Gastroenterology; 2007 Apr; 132(4):1465-75. PubMed ID: 17433324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic expression of a COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells.
    Huang JJ; Lin MC; Bai YX; Jing DD; Wong BC; Han SW; Lin J; Xu B; Huang CF; Kung HF
    Cancer Res; 2002 Jun; 62(11):3226-32. PubMed ID: 12036938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
    Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.